Welcome to Enabled Therapeutics, formerly known as Mercaptor. We are excited to share that all information on our website including our Capton intellectual property and approach is now managed by the founders of Enabled Therapeutics. This marks an exciting new phase in the development of Captons, and we look forward to advancing therapeutic solutions. All historical news below refers to Mercaptor, our former name.
Watch CEO Sara Isbell Speak at the VII Private Investment Forum Worldwide in Zurich
The VII Zurich Private Investment Forum Worldwide was held on April 9, 2019 in Baur Au Lac, Zurich, Switzerland. Mercaptor Discoveries’ CEO Sara Isbell presented
Mercaptor Discoveries Bets on Captons™ to Reinvigorate the Stalled Promise of Stem Cells
Mercaptor Discoveries (Mercaptor), a company developing Captons™, neuroprotectants that become active exclusively at the site of injury, announced today that it will incorporate stem cells
Mercaptains and Mutts Hike to Ammo Hill on the Longest Day to Stand Up to the Darkness of Alzheimer’s Disease
June 21, 2019, also known as the summer solstice and the Longest Day of the year, was filled with sunshine, smiles and great company. A
Mercaptor Team Member Spotlight: Amanda Ko
Mercaptor Discoveries is made up of incredibly talented people who pursue science with the goal of helping millions who suffer from neurodegenerative conditions including #ALS, #CTE, #TBI, #MS and
Mercaptor Discoveries CEO to Speak at Horasis Global Meeting in Cascais, Portugal April 7, 2019 and Private Investment Forum Worldwide in Zurich April 9
Sara Isbell, CEO, President and Co-Founder of Mercaptor Discoveries, will be a speaker and panel chairperson at the Horasis Global Meeting in Cascais, Portugal April 7, 2019. Isbell will also
Mercaptor Team Member Spotlight: Esmeralda Ponce
Mercaptor Discoveries is made up of amazing people who pursue science with the goal of helping millions who suffer from neurodegenerative conditions including #ALS, #CTE,